We provide information for people affected by cancer that is accessible, comprehensive and easy to read. Sally Tweddle was an educationalist with an interest in literacy. Her husband's cancer and their search for cancer information online inspired CancerHelp UK. The management of the site passed to The Cancer Research Campaign in In the increasingly competitive environment of academic research funding, CRI's ability to fund additional fellowship awards helps to secure the future of immunological and cancer immunological research.
This association of biotech and pharma companies as well as academic institutions engaged in cancer immunotherapy development extended the scope of CRI's impact beyond academic research and early clinical discovery—now covering later-phase clinical development typically led by industry.
In , the association renamed itself the Cancer Immunotherapy Consortium to better reflect the group's mission to advance the development of all cancer immunotherapies beyond just vaccines, and in , further refined its scope to function as a "think-tank" devoted to addressing primarily industry-facing issues related to immunotherapy drug development. In , CRI took an important strategic step forward in realizing its mission to conquer cancer through immunotherapy with the launch of the Cancer Vaccine Acceleration Fund.
The Fund is an innovative model for philanthropic investment in early-stage clinical development of promising cancer immunotherapies that have been prioritized by our scientific leadership based on their potential to revolutionize cancer treatment in the near term.
The Clinical Accelerator has established collaborative relationships across academia and industry, gaining access to highly promising immunotherapies and designing clinical trials that not only answer important scientific questions aimed at improving immunotherapy's effectiveness in more types of cancer, but also give patients opportunity to receive cutting-edge cancer treatment.
Sadly, Dr. Old passed away in November of that year. CRI established the endowed Lloyd J. Old Award in Cancer Immunology. At the helm of CRI's scientific leadership today are two highly distinguished cancer immunologists who both worked closely with Dr. Old and who have been members of the CRI community for many years. Wolchok, M. CRI named James P. Allison, Ph.
Old's successor as director of the Scientific Advisory Council. The combined clinical and laboratory expertise of Wolchok and Allison ensures CRI has a solid foundation as more promising cancer immunotherapies make the transition from laboratory to clinic and beyond.
As cancer immunotherapy becomes increasingly available as a treatment option for patients, the need grows to provide trusted, easy-to-understand information to patients and caregivers who are trying to make sense of this new approach to cancer treatment.
The site offers information about immunotherapy for many different kinds of cancer, features stories from patients who have received immunotherapy treatment, connects users to others willing to answer questions about their personal experiences with immunotherapy, and helps patients and caregivers locate immunotherapy clinical trials.
Today, virtually every major research institution in the world working in immunology and immunotherapy has scientists on staff who have been or are currently being funded by CRI, with fresh talent on the way. The journey begun by Dr.
Collaboration with the many others who have now joined in our belief that immunotherapy holds the key to conquering all cancers will be a cornerstone of our strategy.
CRI will continue to be a pioneer and leader in bringing immunotherapies to more cancer patients by:. Our vision is to bring forward the day when all cancers are cured. Our new strategy will give us the foundations we need to tackle the challenges ahead.
Our strategy to beat cancer sooner. The press office offers a service to journalists who are looking for information about cancer, research and fundraising initiatives. Free leaflets, posters and newsletters on prevention, diagnosis and understanding cancer by CRUK. Skip to main content. Research in molecular imaging, genomics, bioinformatics and computational biology. Research focused on specific cancers, which form a link between laboratory and clinic.
Clinical investigations including experimental medicine clinical trials and, in the longer term, population-based studies in screening and prevention. Study at Cambridge Undergraduate Graduate International students Continuing education Executive and professional education Courses in education.
0コメント